• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

使用三氧化二砷成功治疗一名正在接受血液透析的急性早幼粒细胞白血病患者。

Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide.

作者信息

Hashimoto Akiko, Tanaka Yasuhiro, Shinzato Isaku

机构信息

Department of Hematology and Clinical Immunology Kobe City Nishi-Kobe Medical Center Kobe Japan.

出版信息

Clin Case Rep. 2021 Jul 23;9(7):e04300. doi: 10.1002/ccr3.4300. eCollection 2021 Jul.

DOI:10.1002/ccr3.4300
PMID:34322239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8299272/
Abstract

A man undergoing hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide can be used safely and effectively for patients with APL under hemodialysis.

摘要

一名正在接受血液透析的男子被诊断为急性早幼粒细胞白血病（APL）。他接受了三氧化二砷单药治疗，并实现了完全分子缓解，且无严重不良事件。三氧化二砷可安全有效地用于接受血液透析的APL患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa7/8299272/303bf75c9bdb/CCR3-9-e04300-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa7/8299272/1e62eb1cca28/CCR3-9-e04300-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa7/8299272/303bf75c9bdb/CCR3-9-e04300-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa7/8299272/1e62eb1cca28/CCR3-9-e04300-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa7/8299272/303bf75c9bdb/CCR3-9-e04300-g001.jpg

相似文献

1
Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide.使用三氧化二砷成功治疗一名正在接受血液透析的急性早幼粒细胞白血病患者。
Clin Case Rep. 2021 Jul 23;9(7):e04300. doi: 10.1002/ccr3.4300. eCollection 2021 Jul.
2
Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide.三氧化二砷成功治疗一名接受血液透析的急性早幼粒细胞白血病患者。
Clin Case Rep. 2021 Jul 23;9(7):e04417. doi: 10.1002/ccr3.4417. eCollection 2021 Jul.
3
Successful treatment of relapsed acute promyelocytic leukemia with arsenic trioxide in a hemodialysis-dependent patient: A case report.砷剂成功治疗依赖血液透析的复发性急性早幼粒细胞白血病患者：一例报告
World J Clin Cases. 2020 Nov 6;8(21):5347-5352. doi: 10.12998/wjcc.v8.i21.5347.
4
Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report.一名依赖血液透析的患者复发急性早幼粒细胞白血病经三氧化二砷治疗：病例报告
J Med Case Rep. 2012 Oct 18;6:355. doi: 10.1186/1752-1947-6-355.
5
Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis.三氧化二砷用于一名接受慢性血液透析患者的急性早幼粒细胞白血病治疗。
Leuk Res Rep. 2022 Mar 25;17:100304. doi: 10.1016/j.lrr.2022.100304. eCollection 2022.
6
Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.三氧化二砷作为急性早幼粒细胞白血病的一线治疗药物。
Am J Health Syst Pharm. 2009 Nov 1;66(21):1913-8. doi: 10.2146/ajhp080342.
7
[All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].全反式维甲酸/三氧化二砷联合治疗一名接受透析的急性早幼粒细胞白血病患者
Rinsho Ketsueki. 2019;60(10):1431-1435. doi: 10.11406/rinketsu.60.1431.
8
Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide.三氧化二砷成功治疗一例复发性急性早幼粒细胞白血病
Intern Med. 2001 Nov;40(11):1136-9. doi: 10.2169/internalmedicine.40.1136.
9
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 Trial.三氧化二砷和全反式维甲酸治疗儿童急性早幼粒细胞白血病的评估：来自儿童肿瘤学组 AAML1331 试验的报告。
JAMA Oncol. 2022 Jan 1;8(1):79-87. doi: 10.1001/jamaoncol.2021.5206.
10
Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia.三氧化二砷在一名依赖血液透析的复发急性早幼粒细胞白血病患者中的应用。
J Oncol Pharm Pract. 2016 Aug;22(4):646-51. doi: 10.1177/1078155215586235. Epub 2015 May 12.

本文引用的文献

1
[All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].全反式维甲酸/三氧化二砷联合治疗一名接受透析的急性早幼粒细胞白血病患者
Rinsho Ketsueki. 2019;60(10):1431-1435. doi: 10.11406/rinketsu.60.1431.
2
The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia.急性早幼粒细胞白血病患者的12年生存、慢性不良反应及砷潴留随访
Blood. 2016 Sep 15;128(11):1525-8. doi: 10.1182/blood-2016-02-699439. Epub 2016 Jul 11.
3
Induction, consolidation, and maintenance therapies with arsenic as a single agent for acute promyelocytic leukaemia in a 11-year follow-up.
单药砷剂用于急性早幼粒细胞白血病的诱导、巩固及维持治疗：11年随访研究
Hematol Oncol. 2017 Mar;35(1):113-117. doi: 10.1002/hon.2253. Epub 2015 Aug 27.
4
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.全反式维甲酸和三氧化二砷联合治疗急性早幼粒细胞白血病。
N Engl J Med. 2013 Jul 11;369(2):111-21. doi: 10.1056/NEJMoa1300874.
5
Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report.一名依赖血液透析的患者复发急性早幼粒细胞白血病经三氧化二砷治疗：病例报告
J Med Case Rep. 2012 Oct 18;6:355. doi: 10.1186/1752-1947-6-355.
6
Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis.血液透析患者急性早幼粒细胞白血病的成功治疗。
Clin Exp Nephrol. 2011 Jun;15(3):434-437. doi: 10.1007/s10157-011-0405-5. Epub 2011 Feb 5.
7
Arsenic trioxide in a hemodialytic patient with acute promyelocytic leukemia.一名急性早幼粒细胞白血病血液透析患者使用三氧化二砷的情况。
Acta Haematol. 2009;122(1):52-3. doi: 10.1159/000243724. Epub 2009 Oct 7.
8
Successful treatment by all-trans retinoic acid in a patient with acute promyelocytic leukemia complicated by liver cirrhosis and polycystic kidney.全反式维甲酸成功治疗一例合并肝硬化和多囊肾的急性早幼粒细胞白血病患者。
Intern Med. 2009;48(18):1691-4. doi: 10.2169/internalmedicine.48.2358. Epub 2009 Sep 15.
9
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity.单药三氧化二砷治疗新诊断的急性早幼粒细胞白血病：疗效持久且毒性极小
Blood. 2006 Apr 1;107(7):2627-32. doi: 10.1182/blood-2005-08-3532. Epub 2005 Dec 13.
10
All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.全反式维甲酸/三氧化二砷联合用药可使新诊断的急性早幼粒细胞白血病患者获得高质量的缓解和生存。
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5328-35. doi: 10.1073/pnas.0400053101. Epub 2004 Mar 24.